Able to communicate well with the investigator, to understand and comply with the requirements of the study.
You may not be if
History of hepatobilliary disease.
Liver disease or liver injury as indicated by abnormal liver function tests.
Chronic infection with Human Immunodeficiency Virus (HIV), Hepatitis B (HBV) or Hepatitis C (HCV).
Fasting triglycerides greater than or equal to 500 mg/dL \[5.65 mmol/L\], or concomitant use of drug treatment for hypertriglyceridemia (fibrates, omega-3 fatty acids, nicotinic acid).
History of pancreatic injury or pancreatitis.
History of hypersensitivity to drugs of similar biological class, FGF21 protein analogue, or Fc fusion proteins.
History of bone disorders or low vitamin D level.
Contraindications to MRI.
Change in body weight (more than 5% self-reported OR 5 kg self-reported change during the previous 3 months).
Use of weight loss drugs.
Enrollment in a diet, weight loss or exercise programs.
Clareo Health | Safety Study of LLF580 in Obese Volunteers
